Trial · NCT03787303
Results by group13
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 13 of 13
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Progression-free Survival at 12 Months Based Upon Clinical and Radiological Assessments Completed as Part of Routine Care | Triiodothyronine (T3) | 4 | Participants | ||
| Number of Patients With Both Metastatic Breast Cancer and Hypothyroidism in All Screened Patients. | Triiodothyronine (T3) | 26 | Participants | ||
| Measurement of Quality of Life Total Score Across Time Using Validated FACT-B Questionnaire | Triiodothyronine (T3) | Baseline | 114 | Standard Deviation 24.56 | score on a scale |
| Measurement of Quality of Life Total Score Across Time Using Validated FACT-B Questionnaire | Triiodothyronine (T3) | At 3 months | 114 | Standard Deviation 16.80 | score on a scale |
| Measurement of Quality of Life Total Score Across Time Using Validated FACT-B Questionnaire | Triiodothyronine (T3) | At 6 months | 116 | Standard Deviation 20.71 | score on a scale |
| Measurement of Quality of Life Total Score Across Time Using Validated FACT-B Questionnaire | Triiodothyronine (T3) | At 9 months | 112 | Standard Deviation 26.92 | score on a scale |
| Measurement of Quality of Life Total Score Across Time Using Validated FACT-B Questionnaire | Triiodothyronine (T3) | At 12 months | 110 | Standard Deviation 23.68 | score on a scale |
| Measurement of Energy Level Across Time Using FACT-B Question. | Triiodothyronine (T3) | Baseline | 2.9 | Standard Deviation 1.07 | score on a scale |
| Measurement of Energy Level Across Time Using FACT-B Question. | Triiodothyronine (T3) | 3 months | 2.4 | Standard Deviation 1.3 | score on a scale |
| Measurement of Energy Level Across Time Using FACT-B Question. | Triiodothyronine (T3) | 6 months | 3.0 | Standard Deviation 1.16 | score on a scale |
| Measurement of Energy Level Across Time Using FACT-B Question. | Triiodothyronine (T3) | 9 months | 3.0 | Standard Deviation 1.53 | score on a scale |
| Measurement of Energy Level Across Time Using FACT-B Question. | Triiodothyronine (T3) | 12 months | 2.6 | Standard Deviation 1.14 | score on a scale |
| Time to Achieve Euthyroid Hypothyroxinemia State | Triiodothyronine (T3) | 59.6 | Standard Deviation 50.64 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03787303/results